Health Outcomes: Real-World Testing for 2026
Boost health outcomes with real-world testing. Learn how to design pilot programs for diverse groups, use REDCap Cloud, and achieve 15% fewer readmissions.
Healthcare AI promises to transform clinical outcomes, reduce costs, and improve patient engagement — but not all innovation is created equal. Some companies optimize algorithms that never reach the bedside. Others build elegant solutions to problems that don’t exist. And a rare few deliver measurable clinical value that changes how care is actually delivered.
The Healthcare AI Innovation Index is a framework for separating genuine innovation from marketing hype. It evaluates companies across six clinical domains using transparent scoring criteria grounded in real-world outcomes data, deployment scale, and evidence quality.
This index covers:
Each spoke in this index provides a deep-dive into one dimension of healthcare AI innovation. Together, they form the most comprehensive framework for evaluating which healthcare AI companies are genuinely advancing the field — and which are running in place.
Use this index as a decision framework when evaluating healthcare AI vendors, investment targets, or deployment partners. Each spoke provides the evidence layer needed to distinguish companies building the future of healthcare from those building the appearance of it.
Boost health outcomes with real-world testing. Learn how to design pilot programs for diverse groups, use REDCap Cloud, and achieve 15% fewer readmissions.
The shift to value-based care is fundamentally re-architecting the competitive field for health tech, particularly within predictive analytics. Fee-for-service point solutions, once viable, are now…
The healthcare AI landscape is awash with claims of innovation, but for health plan executives and HR buyers, the true measure of advancement isn’t technological…
When evaluating the most innovative AI health companies, particularly those recognized with accolades like Fast Company’s “Most Innovative Companies” in 2026, the true measure of…
The healthcare industry grapples with an administrative burden estimated to cost hundreds of billions annually, with prior authorization alone accounting for a significant chunk. While…
In cardiovascular prevention, smart investors know the difference between a cool algorithm and a real business. While everyone’s chasing the latest AI trend, the money…
The idea that machine learning can spot clinical deterioration before symptoms even appear is a great story, one that could move medicine from being reactive…
Hello Heart’s ability to give a 10-day early cardiac warning, a world away from the standard 10-year clinical risk model, is what got it onto…
Generative AI ambient scribes are heralded as a panacea for physician burnout, promising to reclaim precious clinical time from the clutches of administrative burden. While…
The old 10-year cardiovascular risk assessment model is being completely upended by the speed and precision of artificial intelligence. Just look at the change coming…